Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 27;22(8):1259.
doi: 10.3390/molecules22081259.

Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration

Jin Woo Park  1 , Seung Rim Hwang  2 , In-Soo Yoon  3
Affiliations
Review

Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration

Jin Woo Park et al. Molecules. .

Abstract

Growth factors are endogenous signaling molecules that regulate cellular responses required for wound healing processes such as migration, proliferation, and differentiation. However, exogenous application of growth factors has limited effectiveness in clinical settings due to their low in vivo stability, restricted absorption through skin around wound lesions, elimination by exudation prior to reaching the wound area, and other unwanted side effects. Sophisticated systems to control the spatio-temporal delivery of growth factors are required for the effective and safe use of growth factors as regenerative treatments in clinical practice, such as biomaterial-based drug delivery systems (DDSs). The current review describes the roles of growth factors in wound healing, their clinical applications for the treatment of chronic wounds, and advances in growth factor-loaded DDSs for enhanced wound healing, focusing on micro- and nano-particulate systems, scaffolds, hydrogels, and other miscellaneous systems.

Keywords: chronic wound; drug delivery system; growth factor; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Cutaneous wounds 3 (A) and 5 days (B) after injury. Growth factors such as fibroblast growth factor (FGF), insulin-like growth factor (IGF), keratinocyte growth factor (KGF), platelet-derived growth factor (PDGF), transforming growth factor (TGF), and vascular endothelial growth factor (VEGF), and proteases such as matrix metalloproteinases (MMPs) and plasminogen activator (PA) are thought to be necessary for cell movement [reproduced with permission from Singer, A.J.; Clark, R.A. Cutaneous wound healing. N. Engl. J. Med. 1999, 341, 738‒746].
Figure 2
Figure 2
Schematic illustration of growth factor-loaded drug delivery systems (DDSs) for enhanced wound healing. DDSs were classified according to their matrix structures, i.e., particulate systems, scaffolds, hydrogels, and miscellaneous strategies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Eaglstein W.H., Falanga V. Chronic wounds. Surg. Clin. N. Am. 1997;77:689–700. doi: 10.1016/S0039-6109(05)70575-2. - DOI - PubMed
    1. Schreml S., Szeimies R.M., Prantl L., Landthaler M., Babilas P. Wound healing in the 21st century. J. Am. Acad. Dermatol. 2010;63:866–881. doi: 10.1016/j.jaad.2009.10.048. - DOI - PubMed
    1. Posnett J., Gottrup F., Lundgren H., Saal G. The resource impact of wounds on health-care providers in Europe. J. Wound Care. 2009;18:154–161. doi: 10.12968/jowc.2009.18.4.41607. - DOI - PubMed
    1. Menke N.B., Ward K.R., Witten T.M., Bonchev D.G., Diegelmann R.F. Impaired wound healing. Clin. Dermatol. 2007;25:19–25. doi: 10.1016/j.clindermatol.2006.12.005. - DOI - PubMed
    1. Macri L., Clark R.A. Tissue engineering for cutaneous wounds: Selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol. Physiol. 2009;22:83–93. doi: 10.1159/000178867. - DOI - PubMed

MeSH terms

Substances